Answering real-world clinical questions using large language model, retrieval-augmented generation, and agentic systems

By sjmartinez • June 13, 2025

Low YS, Jackson ML, Hyde RJ, Brown RE, Sanghavi NM, Baldwin JD, Pike CW, Muralidharan J, Hui G, Alexander N, Hassan H, Nene RV, Pike M, Pokrzywa CJ, Vedak S, Yan AP, Yao DH, Zipursky AR, Dinh C, Ballentine P, Derieg DC, Polony V, Chawdry RN, Davies J, Hyde BB, Shah NH, Gombar S. Answering real-world clinical questions using large language model, retrieval-augmented generation, and agentic systems. Digit Health. 2025 Jun 9;11:20552076251348850. doi: 10.1177/20552076251348850. PMID: 40510193; PMCID: PMC12159471.

Tags: Artificial intelligence, Cohort study, evidence-based medicine, Fellow, Hematology/Oncology, Large language models, Publications, retrieval-augmented generation

Trial design and end points in hepatocellular carcinoma: an EASL-AASLD-ILCA consensus statement

Llovet JM, Mauro E, Rimassa L, Mazzaferro V, Pinter M, Kelley RK, Chan SL, Kulik L, Pillai A, Roberts L, Sangro B, Casanovas T, Kaplan[...]

Severe autoimmunity after checkpoint inhibitor therapy in a patient with autoimmune polyglandular syndrome type 1

Lim A, Peluso EM, Downs IA, Horwich BH, Velez-Velez MA, Lechner MG. Severe autoimmunity after checkpoint inhibitor therapy in a patient with autoimmune polyglandular syndrome[...]

A phase 1 trial of HPV16 E7 T-cell receptor-engineered T cells in patients with relapsed/refractory HPV16-positive cancers (KITE-439 trial)

Kirtane K, Niu J, Blumenschein G, Massarelli E, Hanna GJ, Lee S, Bishop MR, Konecny GE, Mao D, Zheng Y, Rodriguez K, Kim JJ, Williams[...]